CoChat

Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Open access
Saito, Makoto, Mansoor, Rashid, Kennon, Kalynn, Anvikar, Anupkumar R., Ashley, Elizabeth A., Chandramohan, Daniel, Cohee, Lauren M., D’Alessandro, Umberto, Genton, Blaise, Gilder, Mary Ellen, Juma, Elizabeth, Kalilani-Phiri, Linda, Kuepfer, Irene, Laufer, Miriam K., Lwin, Khin Maung, Meshnick, Steven R., Mosha, Dominic, Muehlenbachs, Atis, Mwapasa, Victor, Mwebaza, Norah, Nambozi, Michael, Ndiaye, Jean-Louis A., Nosten, François, Nyunt, Myaing, Ogutu, Bernhards, Parikh, Sunil, Paw, Moo Kho, Phyo, Aung Pyae, Pimanpanarak, Mupawjay, Piola, Patrice, Rijken, Marcus J., Sriprawat, Kanlaya, Tagbor, Harry K., Tarning, Joel, Tinto, Halidou, Valéa, Innocent, Valecha, Neena, White, Nicholas J., Wiladphaingern, Jacher, Stepniewska, Kasia, McGready, Rose, Guérin, Philippe J. · 2020 · BMC Medicine
Cited by 23

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Background: Malaria in pregnancy, including asymptomatic infection, has a detrimental impact on foetal development. Individual patient data (IPD) meta-analysis was conducted to compare the association between antimalarial treatments and adverse pregnancy outcomes, including placental malaria, accompanied with the gestational age at diagnosis of uncomplicated falciparum malaria infection. Methods: A systematic review and one-stage IPD meta-analysis of studies assessing the efficacy of artemisinin-based and quinine-based treatments for patent microscopic uncomplicated falciparum malaria infection (hereinafter uncomplicated falciparum malaria) in pregnancy was conducted. The risks of stillbirth (pregnancy loss at ≥ 28.0 weeks of gestation), moderate to late preterm birth (PTB, live birth between 32.0 and < 37.0 weeks), small for gestational age (SGA, birthweight of < 10th percentile), and placental malaria (defined as deposition of malaria pigment in the placenta with or without parasites) after different treatments of uncomplicated falciparum malaria were assessed by mixed-effects logistic regression, using artemether-lumefantrine, the most used antimalarial, as the reference standard. Registration PROSPERO: CRD42018104013. Results: Of the 22 eligible studies (n = 5015), IPD from16 studies were shared, representing 95.0% (n = 4765) of the women enrolled in literature. Malaria treatment in this pooled analysis mostly occurred in the second (68.4%, 3064/4501) or third trimester (31.6%, 1421/4501), with gestational age confirmed by ultrasound in 91.5% (4120/4503). Quinine (n = 184) and five commonly used artemisinin-based combination therapies (ACTs) were included: artemether-lumefantrine (n = 1087), artesunate-amodiaquine (n = 775), artesunate-mefloquine (n = 965), and dihydroartemisinin-piperaquine (n = 837). The overall pooled proportion of stillbirth was 1.1% (84/4361), PTB 10.0% (619/4131), SGA 32.3% (1007/3707), and placental malaria 80.1% (2543/3035), and there were no significant differences of considered outcomes by ACT. Higher parasitaemia before treatment was associated with a higher risk of SGA (adjusted odds ratio [aOR] 1.14 per 10-fold increase, 95% confidence interval [CI] 1.03 to 1.26,p = 0.009) and deposition of malaria pigment in the placenta (aOR 1.67 per 10-fold increase, 95% CI 1.42 to 1.96,p < 0.001). Conclusions: The risks of stillbirth, PTB, SGA, and placental malaria were not different between the commonly used ACTs. The risk of SGA was high among pregnant women infected with falciparum malaria despite treatment with highly effective drugs. Reduction of malaria-associated adverse birth outcomes requires effective prevention in pregnant women.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-020-01592-z

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 23

Metadata

Authors
Saito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., Juma, E., Kalilani-Phiri, L., Kuepfer, I., Laufer, M. K., Lwin, K. M., Meshnick, S. R., Mosha, D., Muehlenbachs, A., Mwapasa, V., Mwebaza, N., Nambozi, M., Ndiaye, J.-L. A., Nosten, F., Nyunt, M., Ogutu, B., Parikh, S., Paw, M. K., Phyo, A. P., Pimanpanarak, M., Piola, P., Rijken, M. J., Sriprawat, K., Tagbor, H. K., Tarning, J., Tinto, H., Valéa, I., Valecha, N., White, N. J., Wiladphaingern, J., Stepniewska, K., McGready, R., & Guérin, P. J.
Venue
BMC Medicine
Published
2020-06-02
Volume
18
Issue
1
Pages
138-138
ISSN
1741-7015 (ISSN-L)
OpenAlex
W3031532630
Cited by
23
References
26
FWCI
0.75
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis. https://app.cochat.ai/papers/10.1186/s12916-020-01592-z
The paper
Saito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., Juma, E., Kalilani-Phiri, L., Kuepfer, I., Laufer, M. K., Lwin, K. M., Meshnick, S. R., Mosha, D., Muehlenbachs, A., Mwapasa, V., . . . Guérin, P. J. (2020). Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis. BMC Medicine. https://doi.org/10.1186/s12916-020-01592-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.